Product name as reported
Proactiv Solution Daily Protection Plus Sunscreen Spf 30: adverse event reports filed with FDA
10,742 reports list it as a suspect or interacting product, 2017–2018.
- 10,742
- reports as suspect product
- 0.1% of all reports · about 1,205 a year
- 0
- reports, 12 months to June 2026
- 0 in the 12 months before
- 0.5%
- marked serious by the reporter
- 57.4% across all reports
- 0%
- record death among outcomes, as reported
- 0 reports · not verified by FDA
Between August 2017 and June 2018, 10,742 adverse event reports received by FDA list the product name "Proactiv Solution Daily Protection Plus Sunscreen Spf 30" as reporters wrote it as a suspect or interacting product. Reports that mention it only as a concomitant medication (19) are left out of every figure here.
In the 12 months to June 2026, 0 reports listed it, and none in the 12 months before. FDA releases FAERS data quarterly, so the newest months are incomplete and grow in later releases. Over its reporting history that is about 1,205 reports a year and 0.1% of the 20,646,523 reports in the database. How many people take it is not in the data, so a count is not a rate of occurrence.
Reporters most often recorded dry skin (34.4%), erythema (32.2%) and skin burning sensation (31.8%). A report can list several reactions, so shares add to more than 100%; 149 different terms appear across these reports. Dry skin is recorded in 34.4% of these reports, against 0.6% of all reports in the database.
0.5% of the reports are marked serious by the reporter; 0% record death among the outcomes and 0.1% record hospitalisation, as reported. 99.4% of the reports came from consumers, and the largest patient age group is 18 to 44 (41.2%). FDA states that "a causal relationship cannot be established between product and reactions listed in a report" and that for any given report "there is no certainty that a suspected drug caused the event."
Reports by month, five years
No report listing Proactiv Solution Daily Protection Plus Sunscreen Spf 30 was received in the five years to June 2026; the latest was received in June 2018.
Reactions recorded in the reports
share of Proactiv Solution Daily Protection Plus Sunscreen Spf 30 reports recording the termall reports in the database
- Dry skindry skin34.4%3,695
- Erythemaskin redness32.2%3,462
- Skin burning sensationburning skin31.8%3,413
- Acneacne24.9%2,679
- Skin exfoliationpeeling skin18.9%2,032
- Skin irritationirritated skin14.1%1,514
- Rashskin rash12.3%1,322
- Pruritusitching10.3%1,111
- Pain of skin9.5%1,018
- Inappropriate schedule of drug administrationthe medicine was taken at the wrong times8.3%890
- Overdosea dose above the recommended amount5.3%564
- Rash papular4.2%451
- Hypersensitivityan allergic-type reaction3.8%404
- Rash macular3.5%371
- Product use in unapproved indicationused for a purpose not on the label3.4%360
- Skin fragility2.9%316
- Urticariahives2.8%297
- Swelling facea swollen face2.8%296
- Underdoseless than the intended dose2.6%277
- Rash erythematousa red rash2.2%241
- Condition aggravatedthe condition being treated got worse2%218
- Skin fissures1.9%207
- Drug ineffectivethe medicine did not work as expected1.8%189
- Skin hyperpigmentation1.7%182
- Skin discolourationa change in skin colour1.5%156
- Dermatitisinflamed skin1.3%138
- Skin swelling1.3%136
- Blistera blister1.2%131
- Eye swellinga swollen eye1.2%130
- Acne cystic1.2%126
Top 30 of 149 MedDRA preferred terms recorded across these reports, with a plain-language gloss where one is available. One report can record several terms. The hollow bar is the share of all reports in the database; it describes the reports, not the patients. FDA states that adverse event reports "represent a small percentage of total usage numbers of a product", that "common products may have a higher number of adverse events due to the higher total number of people using the product", and that the data "by themselves are not an indicator of the safety profile of the drug or biologic."
Outcomes recorded
Outcome flags as the reporter set them; a report can carry several, and "other serious" is FDA's own category for serious reports outside the named outcomes. Grey bar: all 20,646,523 reports. FDA has not verified any outcome and states that the reports "cannot be used to estimate the incidence of these events."
Patients and reporters
Patient age
Patient sex
Who reported
Age and sex as stated in the report; the reporter's qualification is the primary source recorded by FDA. 100% of reports give the United States as the country of the event or reporter.
Reason for use recorded
| Indication as recorded (MedDRA) | Reports | Share |
|---|---|---|
| Acne | 6,311 | 58.8% |
| Skin hyperpigmentation | 78 | 0.7% |
| Seborrhoea | 75 | 0.7% |
| Acne cystic | 71 | 0.7% |
| Rash papular | 45 | 0.4% |
| Rash | 38 | 0.4% |
The indication field is filled in by the reporter and is often blank; shares are of all 10,742 reports.
In context
| Measure | Proactiv Solution Daily Protection Plus Sunscreen Spf 30 | All reports |
|---|---|---|
| Reports as suspect product | 10,742 | 20,646,523 |
| Share of that pool | — | 0.1% |
| Reports, latest 12 months | 0 | 1,332,454 |
| Marked serious | 0.5% | 57.4% |
| Death recorded among outcomes, per 1,000 reports | 0 | 91 |
| Hospitalisation recorded, per 1,000 reports | 1 | 213 |
| Consumer-filed share | 99.4% | 45.8% |
| Top term, share of reports | Dry skin 34.4% | 0.6% |
Shares are of reports, not of patients treated. The number of people taking a product is not in the data, so none of these figures is a rate, and differences between columns reflect who takes a product, who reports and how long it has been sold. FDA states that adverse event reports "represent a small percentage of total usage numbers of a product", that "common products may have a higher number of adverse events due to the higher total number of people using the product", and that the data "by themselves are not an indicator of the safety profile of the drug or biologic."
Questions about Proactiv Solution Daily Protection Plus Sunscreen Spf 30 reports
How many adverse event reports has FDA received for Proactiv Solution Daily Protection Plus Sunscreen Spf 30?
10,742 reports list Proactiv Solution Daily Protection Plus Sunscreen Spf 30 as a suspect or interacting product in the openFDA FAERS release of 28 Sep 2026, covering reports received through June 2026. 0 of them arrived in the latest 12 months. Another 19 list it only as a concomitant medication.
What reactions are recorded in Proactiv Solution Daily Protection Plus Sunscreen Spf 30 reports?
dry skin (34.4%), erythema (32.2%), skin burning sensation (31.8%), acne (24.9%) and skin exfoliation (18.9%). These are MedDRA preferred terms coded from what the reporter described; a report can list several, and a term's presence is not a finding that Proactiv Solution Daily Protection Plus Sunscreen Spf 30 was responsible.
How serious are the reports?
0.5% are marked serious by the reporter. Among the outcomes recorded, 0% of reports include death and 0.1% include hospitalisation. FDA has not verified these outcomes and states that the reports "cannot be used to estimate the incidence" of the events.
Who files these reports?
consumer or non-health professional (99.4%), other health professional (0.5%) and physician (0.1%). Most reports reach FDA through the manufacturer, which must forward reports it receives.
Are reports for Proactiv Solution Daily Protection Plus Sunscreen Spf 30 rising?
0 reports in the 12 months to June 2026, and none in the 12 months before. FDA releases FAERS data quarterly, so the newest months are incomplete and grow in later releases. Counts also move with how many people take a product, its time on the market and publicity.
Do these reports show that Proactiv Solution Daily Protection Plus Sunscreen Spf 30 was responsible for these reactions?
No. FDA states that "a causal relationship cannot be established between product and reactions listed in a report" and that for any given report "there is no certainty that a suspected drug caused the event." The reaction may relate to the condition being treated, to other medicines, or to something else.
Is this a list of the side effects of Proactiv Solution Daily Protection Plus Sunscreen Spf 30?
No. It is a count of what was reported to FDA. The adverse reactions observed in clinical studies are printed on the FDA-approved label, which a pharmacist or clinician can go through with you.
How do I report an adverse event?
Consumers and health professionals can report to FDA through MedWatch (Form FDA 3500 online, or 1-800-FDA-1088), or to the manufacturer, which must pass reports on. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Drug Adverse Event (FAERS) bulk export released 28 Sep 2026, which holds reports FDA received through 30 Jun 2026. Drug names are as reported, resolved to the brand or generic name on the FDA label where openFDA's harmonisation matched them; classes are the pharmacologic class (EPC) from the label and the National Drug Code Directory of 17 Sep 2026. A report counts here when it lists Proactiv Solution Daily Protection Plus Sunscreen Spf 30 as a suspect or interacting product; reports listing it only as a concomitant medication (19) are excluded. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.